Many of the ideas to reinvent learning and education specified in the strategic planning initiative known as UCSF 2.0 were discussed during the UCSF School of Medicine retreat.
TID: 3 VID: 1
One of the major themes to emerge in the planning initiative known as UCSF 2.0 is for the University to take the lead to advance the emerging field of precision medicine.
As players from a wide range of industries continue to venture into health and health care, it will be imperative for UCSF to form new partnerships to address familiar health challenges in creative, novel ways.
Harvey V. Fineberg, MD, PhD, MPP, the President of the Institute of Medicine, will come to UCSF for a yearlong appointment as a Presidential Chair beginning in September.
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
A scientific team led by the Gladstone Institutes and UCSF has discovered that a common form of a gene already associated with long life also improves learning and memory.
Eight UCSF faculty members have been honored with the prestigious Academic Senate Awards in three categories: Faculty Research Lecturer, Distinction in Mentoring and Distinction in Teaching.
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
The Food and Drug Administration has selected UCSF as the site of a new regulatory science center on the West Coast. The center aims to spur innovative approaches in drug development that will support the FDA’s ability to evaluate and approve safe and effective new medications.